A S Gallus, J Hirsh. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Administration, OralAncrod/therapeutic useAnticoagulants/pharmacologyBlood Coagulation TestsDose-Response Relationship, DrugDrug Administration ScheduleFemaleFibrinolysis/drug effectsHeparin/adverse effectsHeparin/therapeutic useHumansInfusions, ParenteralInjections, IntravenousPlasminogen Activators/bloodPregnancyPulmonary Embolism/drug therapyPulmonary Embolism/surgeryStreptokinase/therapeutic useThrombophlebitis/drug therapyThrombophlebitis/surgeryThrombophlebitis/therapyUrokinase-Type Plasminogen Activator/therapeutic useVitamin K/antagonists & inhibitors
Substances: See more » AnticoagulantsVitamin KHeparinStreptokinaseAncrodPlasminogen ActivatorsUrokinase-Type Plasminogen Activator
Year: 1976 PMID: 798277
Source DB: PubMed Journal: Semin Thromb Hemost ISSN: 0094-6176 Impact factor: 4.180